ABBV - CIK 0001551152
AbbVie Inc. (ABBV) reported revenue of $61.16B for fiscal year 2025, up 8.6% from $56.33B in fiscal 2024. The figure comes from the company's audited annual report as filed with the SEC.
| Quarter | Period end | revenue |
|---|---|---|
| Q1 | 2025-03-31 | $13.34B |
| Q2 | 2025-06-30 | $15.42B |
| Q3 | 2025-09-30 | $15.78B |
| Q4 | 2025-12-31 | $16.62B |
Calendar quarters as standardized by SEC XBRL frames; the company's fiscal calendar may offset from calendar quarters.
AbbVie Inc. (ABBV) reported revenue of $61.16B for fiscal year 2025, up 8.6% from $56.33B in fiscal 2024. The figure comes from the company's audited annual report as filed with the SEC.
See the full ABBV revenue history or the complete income statement.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.